Evaluation of Endogenous TRP Agonists in Human Burns

内源性 TRP 激动剂在人体烧伤中的评价

基本信息

项目摘要

Abstract: Evaluation of Endogenous TRP Agonists in Human Burns Burns often lead to persistent pain not well managed by available analgesics. The mechanisms of burn pain are incompletely understood. However, t h e TRPV1 (transient receptor potential V1) receptor appears to be pivotally involved in post-burn pain. In our preliminary data, ~67% of post-burn thermal hyperalgesia is blocked by peripheral injection of a TRPV1 receptor antagonist. In addition, extracts of burned human skin produce thermal hyperalgesia when injected into rats via a TRPV1 receptor mechanism. These novel data suggest that TRPV1 significantly contributes to post-thermal burn injuries. Interestingly, the precise mechanism(s) for the activation of TRPV1 remains unknown. Converging evidence indicates that oxidized lipids derived from linoleic or arachidonic acid are released during tissue injury and activate TRPV1 and/or TRPA1, resulting in nociceptor depolarization and pain. Many of these lipids are formed by the actions of enzymes such as cytochrome P450s (CYP) or lipoxygenase (LOX). This is of particular significance since analysis of the GLUE Grant indicates that transcripts encoding these enzymes are elevated as early as 0-3 days after burns. Therefore, we propose the central hypothesis that oxidized lipids are enzymatically formed after human burn injuries and contribute to post-burn pain by activation of TRPV1 and/or TRPA1. The present Aims will: Specific Aim 1: Identify enzymes that oxidize linoleic acid to form metabolites that activate TRPV1 or TRPA1. We have analyzed the NIGMS-supported GLUE Grant microarray database of transcripts from skin with burn injury vs. control human skin and found significantly elevated levels of CYPs and LOXs that persist for up to 12 months. This Aim will use a COS expression system to evaluate whether these enzymes are capable of oxidizing linoleic acid into TRPV1 or TRPA1 agonists using patch clamp electrophysiology and determine the functional activity of these compounds in preclinical studies. Additional studies will evaluate possible entourage interactions among these lipids for activating TRP channels. Specific Aim 2: Identify enzymes that oxidize arachidonic acid to form metabolites that activate TRPV1 or TRPA1. Aim 2 will use the same approach as Aim 1, but will focus on arachidonic acid metabolites. This novel hypothesis has strong scientific and medical implications. From a scientific perspective, it expands the focus of TRPV1 from being a detector of transient heat, to a detector of oxidized lipids released from burned skin long after the heat-induced injury. From a medical perspective, this hypothesis is innovative since it leads to a fundamentally new pharmacological approach for treating burn pain - by blocking the enzymatic synthesis of TRPV1- and/or TRPA1-active compounds released from tissues after burns. The present proposal is designed to comprehensively test this potentially ground-breaking hypothesis of persistent post-burn pain.
翻译后摘要:在人类烧伤内源性TRP激动剂的评价 烧伤经常导致持续性疼痛,可用的止痛药不能很好地控制。烧伤的机制 疼痛是不完全理解的。然而,TRPV 1(瞬时受体电位V1)受体出现, 与烧伤后疼痛密切相关在我们的初步数据中,约67%的烧伤后热痛觉过敏是由 通过外周注射TRPV 1受体拮抗剂阻断。此外,烧伤人皮肤的提取物 当通过TRPV 1受体机制注射到大鼠中时产生热痛觉过敏。这些新数据 表明TRPV 1显著促进热烧伤后损伤。有趣的是, TRPV 1的激活机制仍然未知。有证据表明 衍生自亚油酸或花生四烯酸的脂质在组织损伤期间释放并激活TRPV 1和/或 TRPA 1,导致伤害感受器去极化和疼痛。这些脂质中的许多是由以下作用形成的: 酶,如细胞色素P450(CYP)或脂氧合酶(LOX)。这一点特别重要,因为 对GLUE Grant的分析表明,编码这些酶的转录本早在0-3 烧伤后几天因此,我们提出了一个中心假设,即氧化脂质是酶促的, 在人烧伤后形成,并通过激活TRPV 1和/或 TRPA 1.目前的目标是: 具体目标1:确定氧化亚油酸形成激活TRPV 1或TRPA 1的代谢物的酶。 我们分析了NIGMS支持的GLUE Grant微阵列数据库中来自烧伤皮肤的转录本 损伤与对照人类皮肤相比,发现CYP和LOX水平显著升高,持续长达12 个月该目的将使用COS表达系统来评估这些酶是否能够 使用膜片钳电生理学将亚油酸氧化成TRPV 1或TRPA 1激动剂,并确定 这些化合物在临床前研究中的功能活性。进一步的研究将评估可能的随行人员 这些脂质之间的相互作用用于激活TRP通道。 具体目标2:鉴定氧化花生四烯酸以形成激活TRPV 1或TRPV 2的代谢物的酶。 TRPA 1.目标2将使用与目标1相同的方法,但将侧重于花生四烯酸代谢物。 这一新的假设具有很强的科学和医学意义。从科学的角度来看, TRPV 1的重点从作为瞬态热的检测器,到从释放的氧化脂质的检测器, 烧伤皮肤后很长一段时间的热诱导损伤。从医学的角度来看,这一假设是创新的,因为 它为治疗烧伤疼痛提供了一种全新的药理学方法--通过阻断 烧伤后从组织释放的TRPV 1和/或TRPA 1活性化合物的合成。现时的建议 旨在全面测试这一潜在的突破性假设的持续烧伤后疼痛。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Kenneth M Hargreaves其他文献

A Retrospective Study Comparing Clinical Outcomes after Obturation with Resilon/epiphany or Gutta-percha/kerr Sealer Comparison of Clinical Outcomes after Obturation with Resilon/epiphany Or
比较 Resilon/epiphany 或 Gutta-percha/kerr Sealer 充填后临床结果的回顾性研究 Resilon/epiphany 或 Gutta-percha/kerr 封闭剂充填后临床结果的比较
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Taylor P Cotton;William G Schindler;S. Schwartz;William R Watson;Kenneth M Hargreaves;De;Gutta;Kerr Sealer
  • 通讯作者:
    Kerr Sealer

Kenneth M Hargreaves的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Kenneth M Hargreaves', 18)}}的其他基金

Mechanisms for Omega-6 Modulation of Primary Afferent Nociceptors
Omega-6 调节初级传入伤害感受器的机制
  • 批准号:
    10019608
  • 财政年份:
    2019
  • 资助金额:
    $ 29.53万
  • 项目类别:
Mechanisms for Omega-6 Modulation of Primary Afferent Nociceptors
Omega-6 调节初级传入伤害感受器的机制
  • 批准号:
    10242063
  • 财政年份:
    2019
  • 资助金额:
    $ 29.53万
  • 项目类别:
Mechanisms for Omega-6 Modulation of Primary Afferent Nociceptors
Omega-6 调节初级传入伤害感受器的机制
  • 批准号:
    9897012
  • 财政年份:
    2019
  • 资助金额:
    $ 29.53万
  • 项目类别:
Mechanisms for Omega-6 Modulation of Primary Afferent Nociceptors
Omega-6 调节初级传入伤害感受器的机制
  • 批准号:
    10472625
  • 财政年份:
    2019
  • 资助金额:
    $ 29.53万
  • 项目类别:
Craniofacial Oral-biology Student Training in Academic Research (COSTAR)
颅面口腔生物学学生学术研究培训(COSTAR)
  • 批准号:
    10197879
  • 财政年份:
    2018
  • 资助金额:
    $ 29.53万
  • 项目类别:
Craniofacial Oral-biology Student Training in Academic Research (COSTAR)
颅面口腔生物学学生学术研究培训(COSTAR)
  • 批准号:
    10424431
  • 财政年份:
    2018
  • 资助金额:
    $ 29.53万
  • 项目类别:
Regulation of TRPV1 Activities by a Sexually Dimorphic Mechanism
性二态机制对 TRPV1 活性的调节
  • 批准号:
    9764343
  • 财政年份:
    2016
  • 资助金额:
    $ 29.53万
  • 项目类别:
Evaluation of Endogenous TRP Agonists in Human Burns
内源性 TRP 激动剂在人体烧伤中的评价
  • 批准号:
    9178073
  • 财政年份:
    2014
  • 资助金额:
    $ 29.53万
  • 项目类别:
REGENERATION OF PULP-DENTIN DEVELOPMENT IN IMMATURE PERMANENT TEETH WITH NECROSIS
坏死的未成熟恒牙牙髓牙本质发育的再生
  • 批准号:
    7876114
  • 财政年份:
    2010
  • 资助金额:
    $ 29.53万
  • 项目类别:
Role of Oxidized Linoleic Acid Metabolites in Pain
氧化亚油酸代谢物在疼痛中的作用
  • 批准号:
    8032353
  • 财政年份:
    2010
  • 资助金额:
    $ 29.53万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 29.53万
  • 项目类别:
    Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 29.53万
  • 项目类别:
    Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 29.53万
  • 项目类别:
    Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 29.53万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 29.53万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 29.53万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 29.53万
  • 项目类别:
    EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 29.53万
  • 项目类别:
    Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 29.53万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 29.53万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了